These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome. Richardson CT; Walsh JH N Engl J Med; 1976 Jan; 294(3):133-5. PubMed ID: 616 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome. Lamers CB; Festen HP; van Tongeren JH Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379 [TBL] [Abstract][Full Text] [Related]
4. [The role of H2 antagonists in Zollinger-Ellison syndrome]. Dammann HG; Walter TA; Müller P; Simon B Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434 [No Abstract] [Full Text] [Related]
5. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome]. Mignon M; Galmiche JP; Bonfils S Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881 [No Abstract] [Full Text] [Related]
6. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists]. Lamers CB Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726 [No Abstract] [Full Text] [Related]
7. Metiamide in the Zollinger-Ellison syndrome. Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)]. Hausamen TU; Fritsch WP; Scholten T; Jungblut R; Strohmeyer G Dtsch Med Wochenschr; 1977 Nov; 102(47):1709-12. PubMed ID: 21785 [TBL] [Abstract][Full Text] [Related]
14. Value of metiamide in the preoperative management of the Zollinger-El. Smith ER; Cuthbert JA; McKessar JH; Francis PN; Little JM Med J Aust; 1976 Jun; 1(26):1000-1. PubMed ID: 979765 [TBL] [Abstract][Full Text] [Related]
15. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome]. Bonfils S; Mignon M; Kloeti G Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of peptic ulcer with histamine H2 receptor antagonists]. Domschke W; Domschke S; Demling L Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347 [TBL] [Abstract][Full Text] [Related]
17. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome. Stabile BE; Ippoliti AF; Walsh JH; Passaro E Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812 [TBL] [Abstract][Full Text] [Related]
18. H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy. McCarthy DM; Olinger EJ; May RJ; Long BW; Gardner JD Ann Intern Med; 1977 Dec; 87(6):668-75. PubMed ID: 22304 [TBL] [Abstract][Full Text] [Related]
19. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)]. Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608 [No Abstract] [Full Text] [Related]
20. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome. Bonfils S; Mignon M; Vallot ; Mayeur S Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775 [No Abstract] [Full Text] [Related] [Next] [New Search]